SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

The sales slipped to Rs. 105.84 millions, down -43.97% for the December 2024 quarter as against Rs. 188.91 millions during the year-ago period.Profit after Tax for the quarter ended December 2024 saw a decline of -66.40% from Rs. 94.20 millions to Rs. 31.65  millions.Operating Profit reported a sharp decline to 49.45 millions from 101.06 millions in the corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202412 202312 % Var 202412 202312 % Var 202403 202303 % Var
Sales 105.84 188.91 -43.97 193.17 636.89 -69.67 745.73 588.34 26.75
Other Income 10.06 5.62 79.00 27.41 14.39 90.48 28.15 11.97 135.17
PBIDT 49.45 101.06 -51.07 81.52 164.09 -50.32 222.18 65.60 238.69
Interest 1.51 0.66 128.79 3.24 2.16 50.00 2.85 2.81 1.42
PBDT 47.94 100.40 -52.25 78.28 161.93 -51.66 219.33 62.79 249.31
Depreciation 6.98 5.12 36.33 20.60 15.33 34.38 20.50 18.38 11.53
PBT 40.96 95.28 -57.01 57.68 146.60 -60.65 198.83 44.41 347.71
TAX 9.31 1.08 762.04 15.78 1.09 1347.71 13.46 0.35 3745.71
Deferred Tax 0.42 0.04 950.00 1.35 0.03 4400.00 -0.16 0.27 -159.26
PAT 31.65 94.20 -66.40 41.90 145.51 -71.20 185.37 44.06 320.72
Equity 437.88 109.47 300.00 437.88 109.47 300.00 109.47 39.14 179.69
PBIDTM(%) 46.72 53.50 -12.66 42.20 25.76 63.80 29.79 11.15 167.21

Shukra Pharma Share Price

33.54 -1.76 (-4.99%)
08-May-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1847.30
Dr. Reddys Lab 1293.25
Cipla 1347.70
Zydus Lifesciences 938.90
Lupin 2377.90
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×